Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
September 28, 2022
24/7 Helpline: 800.272.3900
New Alzheimer’s drug shows promise in clinical trial
The experimental drug lecanemab helped slow cognitive decline by 27% among people living with early Alzheimer's disease, according to topline Phase 3 clinical trial results reported by Eisai and Biogen. The Alzheimer’s Association believes these are the most encouraging results in clinical trials treating the underlying causes of Alzheimer’s to date.

Click here to read more
Mother-daughter quilting project inspires connection
Alzheimer’s Association National Early-Stage Advisor Reda Harrison was diagnosed with mild cognitive impairment in 2018 at age 58. Understanding the power of family, Reda and her daughter Emily are making the most of their time together by working on a quilting project that may take over 100 hours to complete.
Click here to read more
Help fight Alzheimer's
Your Local Community
Procter & Gamble continues its support of dementia caregivers
Since 2017, Procter & Gamble has teamed with the Alzheimer’s Association to help families and caregivers keep their loved ones living with dementia safe through the Home Safety Checklist, support of the Association’s 24/7 Helpline and the soon-to-be-updated Alzheimer’s Navigator®. P&G employees, friends and family will also be participating this fall in the Walk to End Alzheimer's® National Team program.
Click here to read more
Create a free, customized action plan with Alzheimer's Navigator.
More Resources: 
Behaviors  | 
My Preferences:
To stop receiving our weekly e-newsletter, simply unsubscribe.
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2022 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.